Fig. 6. cG-PDE activity is significantly inhibited by capa-1 peptide. cGK (A) and
cG-PDE (B) activities were assayed in tubule preparations from
forR and fors animals as described,
under control and capa-1-stimulated conditions. cGK activity was assessed in
the presence of cGMP. Tubules were pre-treated with capa-1 (10-7
mol l-1) (Kean et al.,
2002) for 10 min, prior to homogenisation and sample preparation.
In order to aid comparison, data for both cGK and cG-PDE activity in the
presence of capa-1 are expressed as % of untreated activity, mean ±
S.E.M. (N=4-6). *Statistically significant data
between controls (100%) and capa-1-treated samples (P<0.05).